Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

Semaglutide was associated with a 70% reduced risk when compared with insulin. The active ingredient found in popular medications for Type 2 diabetes and weight loss, including Ozempic and Wegovy ...

Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other ...

Researchers at Case Western Reserve school of Medicine looked at nearly one million patients in the U.S. with Type 2 diabetes ...

Share on Pinterest Semaglutide, the active ingredient in Ozempic and Wegovy ... how the intervention affects their outcomes. RCTs are considered to be the gold standard for evaluating the safety ...

Supplements promising similar results to Ozempic have taken over social media, but the TGA and health experts have concerns.

Researchers have discovered that semaglutide weight loss drugs like Ozempic may reduce the risk of early-onset colorectal cancer (CRC) in diabetes patients.

According to a study published on October 24, 2024, in the journal Alzheimer’s & Dementia, the type 2 diabetes and weight loss drug semaglutide (sold under the brand names Ozempic, Wegovy ...